We identified a novel AGO2/miR-185-3p/NRP1 regulatory axis that modulates EMT and the metastatic capability of CRC cells, which might represent a regulatory process for cancer cell migration and metastasis in general (Fig. 6L). This evidence concerns the gene AGO2 and colorectal carcinoma.